chr10-86452020-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_015045.5(WAPL):c.3061G>A(p.Asp1021Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015045.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WAPL | NM_015045.5 | c.3061G>A | p.Asp1021Asn | missense_variant | 15/19 | ENST00000298767.10 | |
WAPL | NM_001318328.2 | c.3043G>A | p.Asp1015Asn | missense_variant | 15/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WAPL | ENST00000298767.10 | c.3061G>A | p.Asp1021Asn | missense_variant | 15/19 | 1 | NM_015045.5 | P1 | |
WAPL | ENST00000372075.2 | c.807+1200G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000954 AC: 24AN: 251476Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135910
GnomAD4 exome AF: 0.0000636 AC: 93AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.0000784 AC XY: 57AN XY: 727242
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2023 | The c.3061G>A (p.D1021N) alteration is located in exon 15 (coding exon 14) of the WAPL gene. This alteration results from a G to A substitution at nucleotide position 3061, causing the aspartic acid (D) at amino acid position 1021 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at